Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Lebrikizumab phase 3 data show improvements in atopic dermatitis symptoms, itch in children
2
Treatment choice for pediatric anxiety may depend on preference and access
3
What pediatricians should know for the upcoming respiratory virus season
4
FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older
5